1-4 of 4
Yong-Yu Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ceramide–Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations

Sachin K. Khiste, Zhijun Liu, Kartik R. Roy, Mohammad B. Uddin, Salman B. Hosain, Xin Gu, Sami Nazzal, Ronald A. Hill, Yong-Yu Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (2): 564–574.
DOI: https://doi.org/10.1158/1535-7163.MCT-19-0366
Published: 06 February 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract LB-A19: Ceramide-Rubusoside, an Ultrasmall Nanomicells Effectively Restores p53 Expression in the Missense Mutant Cancer Cells

Yong-Yu Liu, Zhijun Liu, Sachin K. Khiste, Salman B. Hosain
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-A19.
DOI: https://doi.org/10.1158/1535-7163.TARG-15-LB-A19
Published: 01 December 2015
View article
Journal Articles

N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

Hongtao Wang, Barry J. Maurer, Yong-Yu Liu, Elaine Wang, Jeremy C. Allegood, Samuel Kelly, Holly Symolon, Ying Liu, Alfred H. Merrill,, Jr., Valérie Gouazé-Andersson, Jing Yuan Yu, Armando E. Giuliano, Myles C. Cabot
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 2967–2976.
DOI: https://doi.org/10.1158/1535-7163.MCT-08-0549
Published: 11 September 2008
View article
PDF
Journal Articles

Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy

Valerie Gouazé, Jing Y. Yu, Richard J. Bleicher, Tie-Yan Han, Yong-Yu Liu, Hongtao Wang, Michael M. Gottesman, Arie Bitterman, Armando E. Giuliano, Myles C. Cabot
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (5): 633–640.
DOI: https://doi.org/10.1158/1535-7163.633.3.5
Published: 12 May 2004
View article